# Tadalafil as Adjuvant Therapy for DMD

> **NCT05195775** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University of Florida** · enrollment: 25 (estimated)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** Tadalafil
- **DRUG:** Tadalafil

## Key facts

- **NCT ID:** NCT05195775
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-12-14
- **Primary completion:** 2025-09-05
- **Final completion:** 2025-09-05
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05195775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05195775, "Tadalafil as Adjuvant Therapy for DMD". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05195775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*